WHO Pharmaceuticals Newsletter No. 2
PVChronicle shares the latest WHO Pharmaceuticals Newsletter No. 2 release. This is newsletter is released by WHO, Six newsletters per year. The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals. The information is produced in the form of résumés in English. Please use WHO e-posting system for receiving PDF copies of the WHO pharmaceuticals newsletter via e-mail. To automatically receive the electronic version of every new issue of the WHO Pharmaceuticals Newsletter, please send a message to firstname.lastname@example.org containing the following message text: “subscribe WHO-PHN.”To unsubscribe from the service, please send a message to email@example.com containing the following message text: “SIGNOFF WHO-PHN”. The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities around the world.
For Subscribing this newsletter: Click Here
It also provides signals based on information derived from Individual Case Safety Reports (ICSRs) available in the WHO Global ICSR database, VigiBase®. This newsletter includes a feature article titled PV strengthening in Armenia and Kyrgyzstan using smart safety surveillance approach; identifying gaps. Safety of Artemisia annua extract in grapeseed oil, Clozapine and Dabigatran several drugs are described in this edition.
Also Read: Pharmacovigilance Companies in Bangalore, the latest most viewed article on our blog, for PharmD Students, Pharmacy and Life Sciences graduates who are in search of Pharmacovigilance Job opportunities in Bangalore. Do not miss to share WHO Pharmaceuticals Newsletter No. 2 on your social connections, Linkedin, Facebook, and Whatsapp.